Abstract
Age: 29 years
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Hou M, Dai K, Peng J. Blood platelet disorders. 2nd ed. Beijing: Science and Technology Literature Press; 2013.
Guzeldemir E. The role of oral hygiene in a patient with idiopathic thrombocytopenic purpura. Int J Dent Hyg. 2009;7(4):289–93.
Javed F, Utreja A, Bello CFO, et al. Oral health status in children with acute lymphoblastic leukemia. Crit Rev Oncol Hematol. 2012;83(3):303–9.
Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114(5):937–51.
Breed CD. Diagnosis, treatment, and nursing care of patients with chronic leukemia. Semin Oncol Nurs. 2003;19(2):109–17.
Wu J, Fantasia JE, Kaplan R. Oral manifestations of acute myelomonocytic leukemia: a case report and review of the classification of leukemias. J Periodontol. 2002;73(6):664–8.
Fatahzadeh M, Krakow AM. Manifestation of acute monocytic leukemia in the oral cavity: a case report. Spec Care Dentist. 2008;28(5):190–4.
Cooper CL, Loewen R, Shore T. Gingival hyperplasia complicating acute myelomonocytic leukemia. J Can Dent Assoc. 2000;66(2):78–9.
Demirer S, Ozdemir H, Sencan M, Marakoglu I. Gingival hyperplasia as an early diagnostic oral manifestation in acute monocytic leukemia: a case report. Eur J Dent. 2007;1(2):111–4.
Begon E, Blum L, Benramdane R, et al. Oral manifestation of T-cell leukemia/lymphoma. Arch Dermatol. 2010;146(7):804–5.
Audouin J, Comperat E, Le TA, et al. Myeloid sarcoma: clinical and morphologic criteria useful for diagnosis. Int J Surg Pathol. 2003;11(4):271–82.
Campidelli C, Agostinelli C, Stitson R, Pileri SA. Myeloid sarcoma: extramedullary manifestation of myeloid disorders. Am J Clin Pathol. 2009;132(3):426–37.
Papamanthos MK, Kolokotronis AE, Skulakis HE, Fericean AM, Zorba MT, Matiakis AT. Acute myeloid leukaemia diagnosed by intra-oral myeloid sarcoma. A case report. Head Neck Pathol. 2010;4(2):132–5.
Goteri G, Ascani G, Messi M, et al. Myeloid sarcoma of the maxillary bone. J Oral Pathol Med. 2006;35(4):254–6.
Soares AF, Aquino AR, Carvalho CH, Nonaka CF, Almeida D, Pinto LP. Frequency of oral mucositis and microbiological analysis in children with acute lymphoblastic leukemia treated with 0.12% chlorhexidine gluconate. Braz Dent J. 2011;22(4):312–6.
Meng W, Zhou Y, Zhang H, et al. Nasal-type NK/T-cell lymphoma with palatal ulcer as the earliest clinical manifestation: a case report with literature review. Pathol Oncol Res. 2010;16(1):133–7.
Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program. 2009;2009:523–31.
Hong J, Park S, Baek HL, et al. Tumor cell nuclear diameter and CD30 expression as potential prognostic parameter in patients with extranodal NK/T-cell lymphoma, nasal type. Int J Clin Exp Pathol. 2012;5(9):939–47.
Yu WW, Hsieh PP, Chuang SS. Cutaneous EBV-positive gammadelta T-cell lymphoma vs. extranodal NK/T-cell lymphoma: a case report and literature review. J Cutan Pathol. 2012;40(3):310–6.
Pongpruttipan T, Sukpanichnant S, Assanasen T, et al. Extranodal NK/T-cell lymphoma, nasal type, includes cases of natural killer cell and alphabeta, gammadelta, and alphabeta/gammadelta T-cell origin: a comprehensive clinicopathologic and phenotypic study. Am J Surg Pathol. 2012;36(4):481–99.
Kawakami K, Ito R, Tono Y, et al. Orbital inflammatory lesion as an initial manifestation of systemic nasal type NK/T-cell lymphoma. J Clin Exp Hematopathol. 2012;52(2):137–9.
Li S, Feng X, Li T, et al. Extranodal NK/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center. Am J Surg Pathol. 2013;37(1):14–23.
Pacino GA, Serrat A, Redondo LM, Verrier A. Langerhans cell histiocytosis: clinical diagnostic features and current concepts. Med Oral. 1999;4(5):607–18.
Dagenais M, Pharoah MJ, Sikorski PA. The radiographic characteristics of histiocytosis X. A study of 29 cases that involve the jaws. Oral Surg Oral Med Oral Pathol. 1992;74(2):230–6.
Duncan WK, Post AC, McCoy BP. Eosinophilic granuloma. Oral Surg Oral Med Oral Pathol. 1988;65(6):736–41.
Hartman KS. Histiocytosis X: a review of 114 cases with oral involvement. Oral Surg Oral Med Oral Pathol. 1980;49(1):38–54.
Egeler RM, D’Angio GJ. Langerhans cell histiocytosis. J Pediatr. 1995;127(1):1–11.
Hernandez-Juyol M, Boj-Quesada JR, Gallego MS. Oral manifestations of Langerhans cell histiocytosis. Case study of a two-year-old boy. Med Oral. 2003;8(1):19–25.
Minguez I, Minguez JM, Bonet J, Penarrocha M, Sanchis JM. Oral manifestations of chronic disseminated histiocytosis. A report of 10 cases. Med Oral. 2004;9(2):152–4. 149–52.
Becelli R, Carboni A, Gianni C, Alterio A, Renzi G. A rare condition of Hand-Schuller-Christian disease. J Craniofac Surg. 2002;13(6):759–61.
Milian MA, Bagan JV, Jimenez Y, Perez A, Scully C, Antoniades D. Langerhans’ cell histiocytosis restricted to the oral mucosa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91(1):76–9.
Madrigal-Martinez-Pereda C, Guerrero-Rodriguez V, Guisado-Moya B, Meniz-Garcia C. Langerhans cell histiocytosis: literature review and descriptive analysis of oral manifestations. Med Oral Patol Oral Cir Bucal. 2009;14(5):E222–8.
Zhang K, Zeng H, Chen WQ. Clinical features and diagnosis of langerhans cell hyperplasia. Ai Zheng. 2006;25(1):88–91.
Li Y, Liu N, Xu Y, et al. Widespread purple bulla-like masses of the oral mucosa. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(5):552–7.
Khan MF, Falk RH. Amyloidosis. Postgrad Med J. 2001;77(913):686–93.
Steciuk A, Dompmartin A, Troussard X, et al. Cutaneous amyloidosis and possible association with systemic amyloidosis. Int J Dermatol. 2002;41(3):127–32; discussion 133–4.
Fahrner KS, Black CC, Gosselin BJ. Localized amyloidosis of the tongue: a review. Am J Otolaryngol. 2004;25(3):186–9.
Angiero F, Seramondi R, Magistro S, et al. Amyloid deposition in the tongue: clinical and histopathological profile. Anticancer Res. 2010;30(7):3009–14.
Danesh F, Ho LT. Dialysis-related amyloidosis: history and clinical manifestations. Semin Dial. 2001;14(2):80–5.
Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. 1997;337(13):898–909.
Kyle RA, Bayrd ED. Amyloidosis: review of 236 cases. Medicine (Baltimore). 1975;54(4):271–99.
Kerner MM, Wang MB, Angier G, Calcaterra TC, Ward PH. Amyloidosis of the head and neck. A clinicopathologic study of the UCLA experience, 1955–1991. Arch Otolaryngol Head Neck Surg. 1995;121(7):778–82.
Rajkumar SV. Multiple myeloma: 2013 update on diagnosis, risk-stratification, and management. Am J Hematol. 2013;88(3):225–35.
Oliveira EV, Pozetti AC, Pozetti EM, Antonio JR, Michalany NS. Primary systemic amyloidosis associated with multiple myeloma. An Bras Dermatol. 2012;87(1):119–22.
Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78(1):21–33.
Prokaeva T, Spencer B, Kaut M, et al. Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival. Arthritis Rheum. 2007;56(11):3858–68.
Chang SS, Lu CL, Tsay SH, Chang FY, Lee SD. Amyloidosis-induced gastrointestinal bleeding in a patient with multiple myeloma. J Clin Gastroenterol. 2001;32(2):161–3.
Thibault I, Vallieres I. Macroglossia due to systemic amyloidosis: is there a role for radiotherapy. Case Rep Oncol. 2011;4(2):392–9.
Bottoni U, Dianzani C, Pranteda G, et al. Florid cutaneous and mucosal papillomatosis with acanthosis nigricans revealing a primary lung cancer. J Eur Acad Dermatol Venereol. 2000;14(3):205–8.
Yeh JS, Munn SE, Plunkett TA, Harper PG, Hopster DJ, du Vivier AW. Coexistence of acanthosis nigricans and the sign of Leser-Trelat in a patient with gastric adenocarcinoma: a case report and literature review. J Am Acad Dermatol. 2000;42(2 Pt 2):357–62.
Tyler MT, Ficarra G, Silverman S Jr, Odom RB, Regezi JA. Malignant acanthosis nigricans with florid papillary oral lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81(4):445–9.
Brinca A, Cardoso JC, Brites MM, Tellechea O, Figueiredo A. Florid cutaneous papillomatosis and acanthosis nigricans maligna revealing gastric adenocarcinoma. An Bras Dermatol. 2011;86(3):573–7.
Weger W, Ginter-Hanselmayer G, Hammer HF, Hodl S. Florid cutaneous papillomatosis with acanthosis nigricans in a patient with carcinomas of the lung and prostate. J Am Acad Dermatol. 2007;57(5):907–8.
Csete B, Moezzi M, Lengyel Z, Hodosi B, Zombai E, Battyani Z. Florid cutaneous papillomatosis leading to social exclusion. Br J Dermatol. 2005;153(3):667–9.
Janniger EJ, Schwartz RA. Florid cutaneous papillomatosis. J Surg Oncol. 2010;102(6):709–12.
Koyama S, Ikeda K, Sato M, et al. Transforming growth factor-alpha (TGF alpha)-producing gastric carcinoma with acanthosis nigricans: an endocrine effect of TGF alpha in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus. J Gastroenterol. 1997;32(1):71–7.
Wang L, Jin X, Zhao X, et al. Focal dermal hypoplasia: updates. Oral Dis. 2014;20(1):17–24.
Goltz RW, Peterson WC, Gorlin RJ, Ravits HG. Focal dermal hypoplasia. Arch Dermatol. 1962;86:708–17.
Lasocki AL, Stark Z, Orchard D. A case of mosaic Goltz syndrome (focal dermal hypoplasia) in a male patient. Australas J Dermatol. 2011;52(1):48–51.
Grzeschik KH, Bornholdt D, Oeffner F, et al. Deficiency of PORCN, a regulator of Wnt signaling, is associated with focal dermal hypoplasia. Nat Genet. 2007;39(7):833–5.
Lombardi MP, Bulk S, Celli J, et al. Mutation update for the PORCN gene. Hum Mutat. 2011;32(7):723–8.
Quain RD, Militello G, Junkins-Hopkins J, Yan AC, Crawford GH. Erythematous atrophic macules and papules following the lines of Blaschko. Focal dermal hypoplasia (FDH), or Goltz syndrome. Arch Dermatol. 2007;143(1):109–14.
Baxter AM, Shaw MJ, Warren K. Dental and oral lesions in two patients with focal dermal hypoplasia (Goltz syndrome). Br Dent J. 2000;189(10):550–3.
Balmer R, Cameron AC, Ades L, Aldred MJ. Enamel defects and lyonization in focal dermal hypoplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98(6):686–91.
Seoane J, Gibson RL, Almagro M, Pintos E. Oral manifestations associated with focal dermal hypoplasia. Dermatology. 2009;219(4):368–70.
Marcus DM, Shore JW, Albert DM. Anophthalmia in the focal dermal hypoplasia syndrome. Arch Ophthalmol. 1990;108(1):96–100.
Prenner JL, Ciaccia S, Capone A Jr, Trese MT. Retinal detachment in focal dermal hypoplasia. Eur J Ophthalmol. 2004;14(2):166–8.
Bhatia AM, Clericuzio CL, Musemeche CA. Congenital ventral hernia in association with focal dermal hypoplasia. Pediatr Dermatol. 1995;12(4):336–9.
Han XY, Wu SS, Conway DH, et al. Truncus arteriosus and other lethal internal anomalies in Goltz syndrome. Am J Med Genet. 2000;90(1):45–8.
Suskan E, Kurkcuoglu N, Uluoglu O. Focal dermal hypoplasia (Goltz syndrome) with horseshoe kidney abnormality. Pediatr Dermatol. 1990;7(4):283–6.
Lopez-Porras RF, Arroyo C, Soto-Vega E. Focal dermal hypoplasia with uterus bicornis and renal ectopia: case report and review of the literature. Case Rep Dermatol. 2011;3(2):158–63.
Kanemura H, Hatakeyama K, Sugita K, Aihara M. Epilepsy in a patient with focal dermal hypoplasia. Pediatr Neurol. 2011;44(2):135–8.
Smigiel R, Jakubiak A, Lombardi MP, et al. Co-occurrence of severe Goltz-Gorlin syndrome and pentalogy of Cantrell—case report and review of the literature. Am J Med Genet A. 2011;155A(5):1102–5.
Reddy J, Laufer MR. Congenital anomalies of the female reproductive tract in a patient with Goltz syndrome. J Pediatr Adolesc Gynecol. 2009;22(4):e71–2.
Kimonis VE, Goldstein AM, Pastakia B, et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet. 1997;69(3):299–308.
Bleeker-Wagemakers LM, Hamel BC, Hennekam RC, Beemer FA, Oorthuys HW. Oculocerebrocutaneous syndrome. J Med Genet. 1990;27(1):69–70.
Prabhu NT, John R, Munshi AK. Rieger’s syndrome: a case report. Quintessence Int. 1997;28(11):749–52.
Happle R, Daniels O, Koopman RJ. MIDAS syndrome (microphthalmia, dermal aplasia, and sclerocornea): an X-linked phenotype distinct from Goltz syndrome. Am J Med Genet. 1993;47(5):710–3.
Alster TS, Wilson F. Focal dermal hypoplasia (Goltz’s syndrome). Treatment of cutaneous lesions with the 585-nm flashlamp-pumped pulsed dye laser. Arch Dermatol. 1995;131(2):143–4.
Liu J, Hsu PT, Vanderwielen BA, Teng JM. Treatment of recalcitrant excessive granulation tissue with photodynamic therapy in an eight-year-old patient with focal dermal hypoplasia syndrome. Pediatr Dermatol. 2012;29(3):324–6.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd. and People's Medical Publishing House
About this chapter
Cite this chapter
Jin, X., Zeng, X., Wu, L. (2018). Oral Mucosal Lesions of Systemic Diseases. In: Chen, Q., Zeng, X. (eds) Case Based Oral Mucosal Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-13-0286-2_10
Download citation
DOI: https://doi.org/10.1007/978-981-13-0286-2_10
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-0285-5
Online ISBN: 978-981-13-0286-2
eBook Packages: MedicineMedicine (R0)